Body Composition

Nomogram predicting short- and long-term outcomes in colon cancer based on CT body composition.

TL;DR

Sarcopenia (low SMI) is a standalone predictor for postoperative complications and recurrence-free survival in colon cancer patients, whereas myosteatosis (low IMAT) independently predicts RFS, and a nomogram based on CT body composition demonstrated strong predictive performance for short- and long-term outcomes.

Key Findings

Low skeletal muscle index (SMI) and hypoalbuminemia were independent risk factors for postoperative complications in colon cancer patients undergoing radical resection.

  • The original cohort comprised 475 patients (272 males, 203 females; mean age 64.8 ± 11.9 years).
  • Postoperative complications occurred in 85 patients (17.8%) in the original cohort.
  • Multivariate analysis identified low SMI as an independent risk variable for postoperative complications (P = 0.025).
  • Hypoalbuminemia was also identified as an independent risk variable for postoperative complications (P = 0.048).
  • Analysis was performed using logistic regression models.

Low IMAT (myosteatosis) was an independent prognostic variable associated with worse recurrence-free survival in colon cancer patients.

  • Low IMAT was associated with worse RFS with HR 2.919 (95% CI: 1.423–5.985, P = 0.003).
  • This finding was identified via Cox proportional hazards multivariate analysis.
  • The median follow-up was 51 months (IQR, 37.5–62.25).
  • IMAT refers to intermuscular adipose tissue measured on CT imaging.

High skeletal muscle index (SMI) was an independent prognostic variable associated with better recurrence-free survival in colon cancer patients.

  • High SMI was associated with improved RFS with HR 0.450 (95% CI: 0.247–0.821, P = 0.009).
  • This finding was identified via Cox proportional hazards multivariate analysis.
  • The median follow-up was 51 months (IQR, 37.5–62.25).
  • Both SMI and IMAT were derived from CT-based body composition analysis.

The nomogram developed for predicting recurrence-free survival demonstrated strong predictive performance in both the original and validation cohorts.

  • In the original cohort (n = 475), AUCs for 1-, 3-, and 5-year RFS were 0.885, 0.867, and 0.868, respectively.
  • In the validation cohort (n = 209, from Weihai Central Hospital Affiliated to Qingdao University), AUCs for 1-, 3-, and 5-year RFS were 0.784, 0.817, and 0.897, respectively.
  • The nomogram was based on independent predictors of RFS identified by Cox proportional hazards regression.
  • The nomogram was described as providing 'strong predictive performance for RFS.'

The study design was a retrospective two-cohort analysis of colon cancer patients who underwent radical surgical resection at two institutions.

  • The original cohort included 475 patients from the Affiliated Hospital of Qingdao University.
  • The validation cohort included 209 patients from Weihai Central Hospital Affiliated to Qingdao University.
  • CT-based body composition parameters (SMI and IMAT) were the primary exposure variables.
  • Cox proportional hazards and logistic regression models were used to analyze associations between body composition and outcomes.

Have a question about this study?

Citation

Lu Z, Yang W, Yang H, Sui X, Liu S, Xu W, et al.. (2026). Nomogram predicting short- and long-term outcomes in colon cancer based on CT body composition.. International journal of colorectal disease. https://doi.org/10.1007/s00384-025-05016-3